TLR4 and autoimmune disease: In addition, in B-chronic lymphoblastic leukemia (B-CLL), the reduced TLR4 expression was associated with increased risk of disease progression and a poor outcome, infectious episodes, and evolution to autoimmune diseases, which suggests an impaired innate immunity45.